Sign Up to Receive Your Personalised Learning Resources
Start Learning
Sign up to view Favourites, Keep Notes and Track CME Credits
Favourites
Durvalumab: A PD-L1 Blocking Antibody for the Treatment of Adult Patients with Locally Advanced or Metastatic Biliary Tract Cancer
View
Carmelo Rizzari: An overview of SIOP Europe
View
Selecting the optimal treatment for patients with chronic myeloid leukaemia after two prior lines of therapy
View
John Mascarenhas, ASH 2022: Pacritinib for the treatment of myelofibrosis and severe thrombocytopenia, the PACIFICA study
View
Sara Tolaney, ASCO 2023: Primary outcome analysis of the phase 3 SONIA trial and the final overall survival results from the phase 3 TROPiCS-02 study
View
Kim Benstead, European Cancer Summit, 2022: Technical advances in cancer training in Europe
View
Mark Litzow, ASH 2022: Blinatumomab for BCR::ABL1 negative B-lineage acute lymphoblastic leukaemia, ECOG-ACRIN E1910 (a phase III study)
View
Ajay Aggarwal, European Cancer Summit 2022: Perspectives of young cancer professionals
View
Lisa Sarfaty: Exploring and addressing inequities in rare diseases
View
Optimizing androgen deprivation therapy (ADT) in advanced prostate cancer
View